Amgen will continue to advance half of the combo, PRMT5 inhibitor AMG 193, for which it is running a mid-stage trial in ...
Citi analyst Geoff Meacham maintained a Hold rating on Amgen (AMGN – Research Report) today and set a price target of $295.00. The company’s ...
Amgen Inc. closed 16.06% short of its 52-week high of $346.85, which the company reached on July 25th.
Piper Sandler analyst David Amsellem reiterated a Buy rating on Amgen (AMGN – Research Report) today and set a price target of $329.00. The ...
Amgen today is the biggest biotechnology company in the world, but its plush headquarters, global reach and tens of thousands of employees belie its humble origins. Founded in 1980 as Applied ...
Biotechnology company, Amgen, has announced that it has entered into a definitive agreement to acquire deCODE Genetics, a global leader in human genetics, for US $415 million. The all-cash ...
SEC Filings provided by EDGAR Online, Inc.
Tesla stock fell Monday amid a fresh TSLA price-target cut as the EV giant's favorability has slumped. TSLA stock dived over ...
People who have trouble breathing as they sleep often turn to ResMed, which makes a face-worn breathing apparatus. Its ...
After hours: 7:56:38 pm GMT-5 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results